Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of life: Erratum.
| Autor: | Chen X; School of Life Sciences, Zhengzhou University, Zhengzhou., Zhao Y; School of Life Sciences, Zhengzhou University, Zhengzhou., Gao Y; School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen, China., Qi Y; School of Life Sciences, Zhengzhou University, Zhengzhou., Du J; School of Life Sciences, Zhengzhou University, Zhengzhou. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Anti-cancer drugs [Anticancer Drugs] 2021 Feb 01; Vol. 32 (2), pp. 345-364. |
| DOI: | 10.1097/CAD.0000000000001029 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|